Xconomy National

Archives

by in

Entry	Author	Date	Location
Pacira Wins FDA Approval of Pain Drug, Cushioning Pain of 3Q Loss	Arlene Weintraub	10/31/11	New York
AdverseEvents.com Seeks to Keep Track of Drug Side Effects the Way the FDA Never Could	Luke Timmerman	09/27/11	San Francisco
Nevro Raises $58M for Anti-Pain Device	Wade Roush	07/20/11	San Francisco
Pfizer buys Icagen	Arlene Weintraub	07/20/11	New York
Institutes Of Medicine Pain Report May Aid Medical Device Makers	Thomas Lee	07/14/11	Boston
Durect Plunges on FDA Ruling	Arlene Weintraub	06/24/11	San Francisco
BioNanomatrix Moves HQ, Awarepoint CEO Talks Strategy, Ambit Raises $30 Million, & More San Diego Life Sciences News	Bruce V. Bigelow	06/16/11	San Diego
AcelRx Prices IPO	Wade Roush	01/21/11	San Francisco
Omeros Nabs $25M from Paul Allen, State Life Sciences Fund to Pursue Elusive Drug Targets	Luke Timmerman	10/25/10	Seattle
Zogenix Files for IPO, Orexigen Licenses Obesity Drug to Takeda, ImThera Raises Capital For Sleep Apnea, & More San Diego Life Science News	Bruce V. Bigelow	09/09/10	San Diego
San Diego’s Zogenix Files for $90M IPO to Expand Development of Needle-Free Injector and Pain Drugs	Bruce V. Bigelow	09/07/10	San Diego
San Diego’s Zogenix Moving Fast to Commercialize Drug-and-Device Combo	Bruce V. Bigelow	08/17/10	San Diego
Ascent Changes to Anchor	Erin Kutz	03/30/10	Boston
Cadence Pharmaceuticals’ Pain Reliever Handed Second Regulatory Setback	Denise Gellene	02/11/10	San Diego
Javelin Pharma Agrees to Merger with Myriad Pharma	Ryan McBride	12/21/09	Boston
Hydra, Cubist Seek New Pain Drugs	Luke Timmerman	10/19/09	Boston
Cadence, Aiming to Reduce Narcotics Use in Hospitals, Gears Up to Market IV Pain Reliever	Luke Timmerman	07/07/09	San Diego
Cadence Applies for FDA Approval	Luke Timmerman	05/14/09	San Diego
Alkermes, Swinging For the Fence, Touts New Anti-Addiction Drug	Luke Timmerman	04/07/09	Boston
And Then There Were 3 at TorreyPines Therapeutics	Juha-Pekka Tikka	04/01/09	San Diego
Pfizer’s VC Leader, Barbara Dalton, on Corporate Venture and Northwest Deal Hunting	Luke Timmerman	03/17/09	Seattle
Cadence Drug Fails to Prevent Hospital Infections; Company Scraps Program	Luke Timmerman	03/12/09	San Diego
Biogen Idec Aims to Regenerate Damaged Nerves, Crack Multi-Billion Dollar Market	Luke Timmerman	03/11/09	Boston
Cadence Raises $86.6M in Private Stock Offering	Luke Timmerman	02/17/09	San Diego
Stopping Migraines Before They Hurt: NeurAxon Pursues New Pain Drug	Luke Timmerman	02/02/09	Boston
Cadence Turns Attention to Marketplace, as IV Pain Reliever Reaches Goals in Clinical Trials	Luke Timmerman	12/18/08	San Diego
Cadence Shares Boom as IV Pain Reliever Reaches Goal in Study	Luke Timmerman	12/17/08	San Diego
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacks	Luke Timmerman	11/17/08	Seattle
Impel NeuroPharma Develops Novel Delivery System to Get Drugs Into the Brain	Luke Timmerman	08/29/08	Seattle
No Headache for NeurAxon: Company Closes $32 Million Financing Round	Robert Buderi	08/20/07	Boston
Page 1 of 1